• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

界面框架残基在决定抗体V(H)/V(L)相互作用强度和抗原结合亲和力中的作用。

The role of interface framework residues in determining antibody V(H)/V(L) interaction strength and antigen-binding affinity.

作者信息

Masuda Kenji, Sakamoto Kenzo, Kojima Miki, Aburatani Takahide, Ueda Takuya, Ueda Hiroshi

机构信息

Department of Integrated Biosciences, Graduate School of Frontier Sciences, University of Tokyo, Chiba, Japan.

出版信息

FEBS J. 2006 May;273(10):2184-94. doi: 10.1111/j.1742-4658.2006.05232.x.

DOI:10.1111/j.1742-4658.2006.05232.x
PMID:16649995
Abstract

While many antibodies with strong antigen-binding affinity have stable variable regions with a strong antibody heavy chain variable region fragment (V(H))/antibody light chain variable region fragment (V(L)) interaction, the anti-lysozyme IgG HyHEL-10 has a fairly strong affinity, yet a very weak V(H)/V(L) interaction strength, in the absence of antigen. To investigate the possible relationship between antigen-binding affinity and V(H)/V(L) interaction strength, a novel phage display system that can switch two display modes was employed. We focused on the two framework region 2 regions of the HyHEL-10 V(H) and V(L), facing each other at the domain interface, and a combinatorial library was made in which each framework region 2 residue was mixed with that of D1.3, which has a far stronger V(H)/V(L) interaction. The phagemid library, encoding V(H) gene 7 and V(L) amber codon gene 9, was used to transform TG-1 (sup+), and the phages displaying functional variable regions were selected. The selected phages were then used to infect a nonsuppressing strain, and the culture supernatant containing V(H)-displaying phages and soluble V(L) fragment was used to evaluate the V(H)/V(L) interaction strength. The results clearly showed the existence of a key framework region 2 residue (H39) that strongly affects V(H)/V(L) interaction strength, and a marked positive correlation between the antigen-binding affinity and the V(H)/V(L) interaction, especially in the presence of a set of particular V(L) residues. The effect of the H39 mutation on the wild-type variable region was also confirmed by a SPR biosensor as a several-fold increase in antigen-binding affinity owing to an increased association rate, while a slight decrease was observed for the single-chain variable region.

摘要

虽然许多具有强抗原结合亲和力的抗体具有稳定的可变区,其抗体重链可变区片段(V(H))/抗体轻链可变区片段(V(L))相互作用很强,但抗溶菌酶IgG HyHEL-10具有相当强的亲和力,然而在没有抗原的情况下,其V(H)/V(L)相互作用强度非常弱。为了研究抗原结合亲和力与V(H)/V(L)相互作用强度之间的可能关系,采用了一种可以切换两种展示模式的新型噬菌体展示系统。我们聚焦于HyHEL-10 V(H)和V(L)在结构域界面相互面对的两个框架区2区域,并构建了一个组合文库,其中每个框架区2残基与D1.3的相应残基混合,D1.3具有更强的V(H)/V(L)相互作用。编码V(H)基因7和V(L)琥珀密码子基因9的噬菌粒文库用于转化TG-1(sup+),并筛选展示功能性可变区的噬菌体。然后将筛选出的噬菌体用于感染非抑制菌株,含有展示V(H)的噬菌体和可溶性V(L)片段的培养上清液用于评估V(H)/V(L)相互作用强度。结果清楚地表明存在一个强烈影响V(H)/V(L)相互作用强度的关键框架区2残基(H39),并且抗原结合亲和力与V(H)/V(L)相互作用之间存在显著的正相关,特别是在存在一组特定V(L)残基的情况下。SPR生物传感器也证实了H39突变对野生型可变区的影响,由于结合速率增加,抗原结合亲和力提高了几倍,而单链可变区则略有下降。

相似文献

1
The role of interface framework residues in determining antibody V(H)/V(L) interaction strength and antigen-binding affinity.界面框架残基在决定抗体V(H)/V(L)相互作用强度和抗原结合亲和力中的作用。
FEBS J. 2006 May;273(10):2184-94. doi: 10.1111/j.1742-4658.2006.05232.x.
2
Requirement for both H and L chain V regions, VH and VK joining amino acids, and the unique H chain D region for the high affinity binding of an anti-phosphotyrosine antibody.抗磷酸酪氨酸抗体的高亲和力结合需要重链和轻链可变区、VH和VK连接氨基酸以及独特的重链D区。
J Immunol. 1993 Apr 15;150(8 Pt 1):3389-96.
3
Human immunoglobulin repertoires against tetanus toxoid contain a large and diverse fraction of high-affinity promiscuous V(H) genes.针对破伤风类毒素的人类免疫球蛋白库包含大量多样的高亲和力混杂V(H)基因。
J Mol Biol. 2009 Apr 3;387(3):548-58. doi: 10.1016/j.jmb.2009.02.009. Epub 2009 Feb 11.
4
Unraveling the effect of changes in conformation and compactness at the antibody V(L)-V(H) interface upon antigen binding.解析抗体V(L)-V(H)界面处构象和紧密性变化对抗原结合的影响。
J Mol Recognit. 1999 Jul-Aug;12(4):267-75. doi: 10.1002/(SICI)1099-1352(199907/08)12:4<267::AID-JMR465>3.0.CO;2-9.
5
Humanization of a murine monoclonal antibody by simultaneous optimization of framework and CDR residues.通过同时优化框架区和互补决定区残基对鼠单克隆抗体进行人源化。
J Mol Biol. 1999 Nov 19;294(1):151-62. doi: 10.1006/jmbi.1999.3141.
6
Guided selection of a pan carcinoma specific antibody reveals similar binding characteristics yet structural divergence between the original murine antibody and its human equivalent.通过指导选择一种泛癌特异性抗体发现,原始鼠源抗体与其人源等效抗体之间具有相似的结合特性,但结构存在差异。
J Mol Biol. 2000 Feb 25;296(3):833-49. doi: 10.1006/jmbi.2000.3512.
7
Anti-estradiol-17beta single-chain Fv fragments: Generation, characterization, gene randomization, and optimized phage display.抗雌二醇-17β单链Fv片段:生成、表征、基因随机化及优化的噬菌体展示
Steroids. 2008 Dec 22;73(14):1485-99. doi: 10.1016/j.steroids.2008.08.009. Epub 2008 Sep 9.
8
Antibody affinity maturation in vitro using unconjugated peptide antigen.体外使用未缀合的肽抗原进行抗体亲和力成熟。
Protein Eng Des Sel. 2010 Apr;23(4):185-93. doi: 10.1093/protein/gzp093. Epub 2010 Feb 1.
9
Human framework adaptation of a mouse anti-human IL-13 antibody.人源框架对鼠抗人 IL-13 抗体的适应性改造。
J Mol Biol. 2010 Apr 30;398(2):214-31. doi: 10.1016/j.jmb.2010.03.004. Epub 2010 Mar 10.
10
Isolation of picomolar affinity anti-c-erbB-2 single-chain Fv by molecular evolution of the complementarity determining regions in the center of the antibody binding site.通过对抗体结合位点中心互补决定区进行分子进化分离出具有皮摩尔亲和力的抗c-erbB-2单链Fv。
J Mol Biol. 1996 Nov 8;263(4):551-67. doi: 10.1006/jmbi.1996.0598.

引用本文的文献

1
Amino Acids Frequency and Interaction Trends: Comprehensive Analysis of Experimentally Validated Viral Antigen-Antibody Complexes.氨基酸频率与相互作用趋势:对经实验验证的病毒抗原-抗体复合物的综合分析
Mol Biotechnol. 2025 Jan 8. doi: 10.1007/s12033-024-01361-w.
2
Defining and Studying B Cell Receptor and TCR Interactions.定义和研究 B 细胞受体和 TCR 相互作用。
J Immunol. 2023 Aug 1;211(3):311-322. doi: 10.4049/jimmunol.2300136.
3
Structural Basis of Antibody Conformation and Stability Modulation by Framework Somatic Hypermutation.
框架体细胞超突变调节抗体构象和稳定性的结构基础。
Front Immunol. 2022 Jan 3;12:811632. doi: 10.3389/fimmu.2021.811632. eCollection 2021.
4
Llamanade: An open-source computational pipeline for robust nanobody humanization. llamanade:一个用于稳健纳米抗体人源化的开源计算流程。
Structure. 2022 Mar 3;30(3):418-429.e3. doi: 10.1016/j.str.2021.11.006. Epub 2021 Dec 10.
5
: an open-source computational pipeline for robust nanobody humanization.用于可靠的纳米抗体人源化的开源计算流程
bioRxiv. 2021 Aug 4:2021.08.03.455003. doi: 10.1101/2021.08.03.455003.
6
Sagacity in antibody humanization for therapeutics, diagnostics and research purposes: considerations of antibody elements and their roles.用于治疗、诊断和研究目的的抗体人源化中的睿智:抗体元件及其作用的考量
Antib Ther. 2020 Apr 18;3(2):71-79. doi: 10.1093/abt/tbaa005. eCollection 2020 Apr.
7
Mutational fitness landscapes reveal genetic and structural improvement pathways for a vaccine-elicited HIV-1 broadly neutralizing antibody.突变适应性景观揭示了一种疫苗诱导的 HIV-1 广谱中和抗体的遗传和结构改善途径。
Proc Natl Acad Sci U S A. 2021 Mar 9;118(10). doi: 10.1073/pnas.2011653118.
8
Bispecific antibodies targeting dual tumor-associated antigens in cancer therapy.癌症治疗中靶向双肿瘤相关抗原的双特异性抗体。
J Cancer Res Clin Oncol. 2020 Dec;146(12):3111-3122. doi: 10.1007/s00432-020-03404-6. Epub 2020 Sep 28.
9
Computational Design of an Allosteric Antibody Switch by Deletion and Rescue of a Complex Structural Constellation.通过删除和挽救复杂结构构型进行变构抗体开关的计算设计
ACS Cent Sci. 2020 Mar 25;6(3):390-403. doi: 10.1021/acscentsci.9b01065. Epub 2020 Mar 11.
10
Development of tibulizumab, a tetravalent bispecific antibody targeting BAFF and IL-17A for the treatment of autoimmune disease.替布珠单抗的研发,一种针对 BAFF 和 IL-17A 的四价双特异性抗体,用于治疗自身免疫性疾病。
MAbs. 2019 Aug/Sep;11(6):1175-1190. doi: 10.1080/19420862.2019.1624463. Epub 2019 Jun 10.